126 related articles for article (PubMed ID: 17579858)
1. Immunological profiling of a panel of human ovarian cancer cell lines.
Carr TM; Adair SJ; Fink MJ; Hogan KT
Cancer Immunol Immunother; 2008 Jan; 57(1):31-42. PubMed ID: 17579858
[TBL] [Abstract][Full Text] [Related]
2. Treatment of ovarian cancer cell lines with 5-aza-2'-deoxycytidine upregulates the expression of cancer-testis antigens and class I major histocompatibility complex-encoded molecules.
Adair SJ; Hogan KT
Cancer Immunol Immunother; 2009 Apr; 58(4):589-601. PubMed ID: 18791715
[TBL] [Abstract][Full Text] [Related]
3. Tumor-associated antigen profiling in breast and ovarian cancer: mRNA, protein or T cell recognition?
Kayser S; Watermann I; Rentzsch C; Weinschenk T; Wallwiener D; Gückel B
J Cancer Res Clin Oncol; 2003 Jul; 129(7):397-409. PubMed ID: 12836015
[TBL] [Abstract][Full Text] [Related]
4. Comparative assessment of MHC antigen expression in bladder and testis tumour biopsies and established urological tumour cell lines: the relevance of cytokine and gene transfection for correction of defective MHC antigens.
Nouri AM; Symes MO
Oncol Rep; 2000; 7(5):959-64. PubMed ID: 10948322
[TBL] [Abstract][Full Text] [Related]
5. Interactions between interferon gamma and retinoic acid with transforming growth factor beta in the induction of immune recognition molecules.
Darley R; Morris A; Passas J; Bateman W
Cancer Immunol Immunother; 1993 Jul; 37(2):112-8. PubMed ID: 8100485
[TBL] [Abstract][Full Text] [Related]
6. Cytokine induced modulation of MHC class I and class II molecules on human cervical epithelial cells.
Ljunggren G; Anderson DJ
J Reprod Immunol; 1998 Jul; 38(2):123-38. PubMed ID: 9730287
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell lines.
Nash MA; Lenzi R; Edwards CL; Kavanagh JJ; Kudelka AP; Verschraegen CF; Platsoucas CD; Freedman RS
Clin Exp Immunol; 1998 May; 112(2):172-80. PubMed ID: 9649178
[TBL] [Abstract][Full Text] [Related]
8. Effect of recombinant human leukocyte, fibroblast, and immune interferons on expression of class I and II major histocompatibility complex and invariant chain in early passage human melanoma cells.
Nisticò P; Tecce R; Giacomini P; Cavallari A; D'Agnano I; Fisher PB; Natali PG
Cancer Res; 1990 Dec; 50(23):7422-9. PubMed ID: 1701342
[TBL] [Abstract][Full Text] [Related]
9. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of transforming growth factor beta 1 and 2 in ovarian carcinoma.
Gordinier ME; Zhang HZ; Patenia R; Levy LB; Atkinson EN; Nash MA; Katz RL; Platsoucas CD; Freedman RS
Clin Cancer Res; 1999 Sep; 5(9):2498-505. PubMed ID: 10499625
[TBL] [Abstract][Full Text] [Related]
11. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
[TBL] [Abstract][Full Text] [Related]
12. Interactions of host IL-6 and IFN-gamma and cancer-derived TGF-beta1 on MHC molecule expression during tumor spontaneous regression.
Hsiao YW; Liao KW; Chung TF; Liu CH; Hsu CD; Chu RM
Cancer Immunol Immunother; 2008 Jul; 57(7):1091-104. PubMed ID: 18259750
[TBL] [Abstract][Full Text] [Related]
13. Modulation by canine interferon-gamma of major histocompatibility complex and tumor-associated antigen expression in canine mammary tumor and melanoma cell lines.
Whitley EM; Bird AC; Zucker KE; Wolfe LG
Anticancer Res; 1995; 15(3):923-9. PubMed ID: 7645983
[TBL] [Abstract][Full Text] [Related]
14. Effect of invariant chain on major histocompatibility complex class I molecule expression and stability on human breast tumor cell lines.
Lin X; Wang X; Capek HL; Simone LC; Tuli A; Morris CR; Reber AJ; Solheim JC
Cancer Immunol Immunother; 2009 May; 58(5):729-36. PubMed ID: 18828016
[TBL] [Abstract][Full Text] [Related]
15. [Identification of T cell epitopes from ovarian cancer associated anti-idiotype antibody].
Li W; Cui H; Chang XH; Cheng HY; Cheng YX; Feng J; Fu TY
Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):764-9. PubMed ID: 19087545
[TBL] [Abstract][Full Text] [Related]
16. Cytokine modulation of antigen expression in human melanoma cell lines derived from primary and metastatic tumour tissues.
Andalib AR; Lawry J; Ali SA; Murray AK; Sisley K; Silcocks P; Herlyn M; Rees RC
Melanoma Res; 1997 Feb; 7(1):32-42. PubMed ID: 9067963
[TBL] [Abstract][Full Text] [Related]
17. Cytokine modulation of costimulatory molecules on human fetal retinal pigment epithelial cells.
Farrokh-Siar L; Rezai KA; Palmer EM; Patel SC; Ernest TJ; van Seventer GA
Curr Eye Res; 2001 Oct; 23(4):285-90. PubMed ID: 11852430
[TBL] [Abstract][Full Text] [Related]
18. Characterization of human non-small cell lung cancer (NSCLC) cell lines for expression of MHC, co-stimulatory molecules and tumor-associated antigens.
Wroblewski JM; Bixby DL; Borowski C; Yannelli JR
Lung Cancer; 2001; 33(2-3):181-94. PubMed ID: 11551413
[TBL] [Abstract][Full Text] [Related]
19. Differential induction by interferons of major histocompatibility complex-encoded and non-major histocompatibility complex-encoded antigens in human breast and ovarian carcinoma cell lines.
Boyer CM; Dawson DV; Neal SE; Winchell LF; Leslie DS; Ring D; Bast RC
Cancer Res; 1989 Jun; 49(11):2928-34. PubMed ID: 2497969
[TBL] [Abstract][Full Text] [Related]
20. HLA restriction and T-cell-receptor V beta gene expression of cytotoxic T lymphocytes reactive with human squamous-cell carcinoma of the head and neck.
Yasumura S; Weidmann E; Hirabayashi H; Johnson JT; Herberman RB; Whiteside TL
Int J Cancer; 1994 May; 57(3):297-305. PubMed ID: 8168988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]